Try our Investor Tool
Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Try our Investor Tool
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for ANGLE plc
Clear Filter
Search
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
3
»
Date / Time
Source
Company
Sector
Market Cap
Announcement
10Mar23 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
09Feb23 14:44
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
10Jan23 18:20
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
05Jan23 07:01
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Business Update
12Dec22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
02Nov22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
18Oct22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
RNS
ANGLE plc
Health
£49.5m
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - First regional distribution agreement
30Sep22 17:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
30Sep22 17:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
29Sep22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Interim Results
28Sep22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
20Jul22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Results of Capital Raise
14Jul22 17:24
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
29Jun22 16:35
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
22Jun22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Partnership with major United States urology group
27May22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
RNS
ANGLE plc
Health
£49.5m
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Preliminary Results
20Apr22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Holding(s) in Company
18Feb22 17:13
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
21Jan22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
01Dec21 18:11
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
01Dec21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
17Nov21 10:32
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
15Nov21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
12Nov21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
02Nov21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Change of Adviser
21Oct21 17:25
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
15Oct21 17:45
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
30Sep21 16:02
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
30Sep21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Interim Results
27Sep21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Director/PDMR Shareholding
09Aug21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
03Aug21 15:13
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
28Jul21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Director/PDMR Shareholding
02Jul21 10:45
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Issue of Equity
30Jun21 15:44
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Result of AGM
25Jun21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Annual General Meeting update
18Jun21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Update on submission for FDA clearance
01Jun21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37
RNS
ANGLE plc
Health
£49.5m
Angle PLC - Exercise of options and total voting rights
11May21 07:00
RNS-R
ANGLE plc
Health
£49.5m
Parsortix study uncovers targets in TNBC patients
30Apr21 11:22
RNS
ANGLE plc
Health
£49.5m
Exercise of options and total voting rights
29Apr21 07:00
RNS
ANGLE plc
Health
£49.5m
Preliminary Results
26Apr21 07:00
RNS
ANGLE plc
Health
£49.5m
Ovarian cancer study patient enrolment completed
16Apr21 07:00
RNS
ANGLE plc
Health
£49.5m
First large-scale pharma services contract secured
15Apr21 16:10
RNS
ANGLE plc
Health
£49.5m
Notice of Preliminary Results and Webcast
12Apr21 07:00
RNS-R
ANGLE plc
Health
£49.5m
ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00
RNS
ANGLE plc
Health
£49.5m
Global launch of clinical services laboratories
«
1
2
3
»
Date / Time
Source
Company
% Chg
10Mar23 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
09Feb23 14:44
RNS
ANGLE plc
-5.70%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
10Jan23 18:20
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
05Jan23 07:01
RNS
ANGLE plc
-5.70%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Business Update
12Dec22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
02Nov22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
18Oct22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
RNS
ANGLE plc
-5.70%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - First regional distribution agreement
30Sep22 17:30
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep22 17:30
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
29Sep22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Interim Results
28Sep22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
RNS
ANGLE plc
-5.70%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
20Jul22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
RNS
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Results of Capital Raise
14Jul22 17:24
RNS
ANGLE plc
-5.70%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
RNS
ANGLE plc
-5.70%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
29Jun22 16:35
RNS
ANGLE plc
-5.70%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
22Jun22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Partnership with major United States urology group
27May22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
RNS
ANGLE plc
-5.70%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Preliminary Results
20Apr22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
RNS
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
18Feb22 17:13
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
21Jan22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
01Dec21 18:11
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
01Dec21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
17Nov21 10:32
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
15Nov21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
12Nov21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
02Nov21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Change of Adviser
21Oct21 17:25
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
15Oct21 17:45
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep21 16:02
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Interim Results
27Sep21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
09Aug21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
03Aug21 15:13
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
28Jul21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34
RNS
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
02Jul21 10:45
RNS
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Jun21 15:44
RNS
ANGLE plc
-5.70%
Angle PLC - Result of AGM
25Jun21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28
RNS
ANGLE plc
-5.70%
Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42
RNS
ANGLE plc
-5.70%
Angle PLC - Annual General Meeting update
18Jun21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Update on submission for FDA clearance
01Jun21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00
RNS
ANGLE plc
-5.70%
Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37
RNS
ANGLE plc
-5.70%
Angle PLC - Exercise of options and total voting rights
11May21 07:00
RNS-R
ANGLE plc
-5.70%
Parsortix study uncovers targets in TNBC patients
30Apr21 11:22
RNS
ANGLE plc
-5.70%
Exercise of options and total voting rights
29Apr21 07:00
RNS
ANGLE plc
-5.70%
Preliminary Results
26Apr21 07:00
RNS
ANGLE plc
-5.70%
Ovarian cancer study patient enrolment completed
16Apr21 07:00
RNS
ANGLE plc
-5.70%
First large-scale pharma services contract secured
15Apr21 16:10
RNS
ANGLE plc
-5.70%
Notice of Preliminary Results and Webcast
12Apr21 07:00
RNS-R
ANGLE plc
-5.70%
ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00
RNS
ANGLE plc
-5.70%
Global launch of clinical services laboratories
«
1
2
3
»
Date / Time
Company
% Chg
10Mar23 07:00
ANGLE plc
-5.70%
Angle PLC - Issue of LTIP Options and Share Options
09Mar23 15:03
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
09Feb23 14:44
ANGLE plc
-5.70%
Angle PLC - Director/PDMR shareholding
19Jan23 07:00
ANGLE plc
-5.70%
Angle PLC - Appointment of Non-Executive Director
11Jan23 17:20
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
10Jan23 18:20
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
05Jan23 07:01
ANGLE plc
-5.70%
Angle PLC - Appointment of Non-Executive Director
05Jan23 07:00
ANGLE plc
-5.70%
Angle PLC - Business Update
12Dec22 07:00
ANGLE plc
-5.70%
Angle PLC - Two Parsortix posters presented at SABCS
02Dec22 17:30
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
02Nov22 07:00
ANGLE plc
-5.70%
Angle PLC - Multiple downstream analysis techniques for CTCs
24Oct22 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix poster presented at ISLB meeting
21Oct22 18:15
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
18Oct22 07:00
ANGLE plc
-5.70%
Angle PLC - Streamlining of operations to increase cash runway
17Oct22 14:23
ANGLE plc
-5.70%
Angle PLC - TR-1: Notification of major holdings
12Oct22 07:00
ANGLE plc
-5.70%
Angle PLC - First regional distribution agreement
30Sep22 17:30
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep22 17:30
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
29Sep22 07:00
ANGLE plc
-5.70%
Angle PLC - Positive headline results from ovarian study
29Sep22 07:00
ANGLE plc
-5.70%
Angle PLC - Interim Results
28Sep22 07:00
ANGLE plc
-5.70%
Angle PLC - Study using Parsortix in head and neck cancer
13Sep22 07:00
ANGLE plc
-5.70%
Angle PLC - New poster presented at ASCP Meeting
12Sep22 07:30
ANGLE plc
-5.70%
Angle PLC - Novel assay predicts malignancy in pelvic mass
01Sep22 07:00
ANGLE plc
-5.70%
Angle PLC - Notice of Interim Results and Webcast
28Jul22 07:00
ANGLE plc
-5.70%
Angle PLC - Novel insight into metastasis in NSCLC patients
20Jul22 14:33
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
20Jul22 07:00
ANGLE plc
-5.70%
Angle PLC - NEW STUDY OF PARSORTIX SYSTEM IN NSCLC
19Jul22 10:00
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
15Jul22 07:00
ANGLE plc
-5.70%
Angle PLC - Results of Capital Raise
14Jul22 17:24
ANGLE plc
-5.70%
Angle PLC - Retail Offer via PrimaryBid
14Jul22 17:23
ANGLE plc
-5.70%
Angle PLC - Proposed Placing and Retail Offer
08Jul22 17:30
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
29Jun22 16:35
ANGLE plc
-5.70%
Angle PLC - Result of 2022 Annual General Meeting
27Jun22 07:00
ANGLE plc
-5.70%
Angle PLC - Spread of breast cancer accelerates during sleep
23Jun22 18:24
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
22Jun22 07:00
ANGLE plc
-5.70%
Angle PLC - Secured contract from pharma services customer
16Jun22 07:00
ANGLE plc
-5.70%
Angle PLC - Predicting immunotherapy response in SCLC
14Jun22 07:00
ANGLE plc
-5.70%
Angle PLC - Potential role of invasive cellular protrusions
30May22 07:00
ANGLE plc
-5.70%
Angle PLC - Partnership with major United States urology group
27May22 07:00
ANGLE plc
-5.70%
Angle PLC - Molecular characterisation of CTCs
25May22 12:30
ANGLE plc
-5.70%
Angle PLC - ANGLE receives FDA clearance for Parsortix
20May22 07:00
ANGLE plc
-5.70%
Angle PLC - Prostate Cancer UK funds new study using Parsortix
28Apr22 07:00
ANGLE plc
-5.70%
Angle PLC - Preliminary Results
20Apr22 07:00
ANGLE plc
-5.70%
Angle PLC - Notice of Preliminary Results and Webcast
14Apr22 07:00
ANGLE plc
-5.70%
Angle PLC - Poster on Parsortix system presented at AACR 2022
01Apr22 07:00
ANGLE plc
-5.70%
Angle PLC - Identifying drug targets in cancer metastasis
29Mar22 07:00
ANGLE plc
-5.70%
Angle PLC - Rapid information on patient response to therapies
25Mar22 07:00
ANGLE plc
-5.70%
Angle PLC - Identifying therapeutic targets in TNBC patients
15Mar22 07:00
ANGLE plc
-5.70%
Angle PLC - Update on laboratory accreditation
02Mar22 18:29
ANGLE plc
-5.70%
Angle PLC - Holding(s) in Company
18Feb22 17:13
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
21Jan22 07:00
ANGLE plc
-5.70%
Angle PLC - Potential in immunotherapy treatment selection
17Jan22 07:00
ANGLE plc
-5.70%
Angle PLC - Concordance of Parsortix with tissue biopsy
13Jan22 07:00
ANGLE plc
-5.70%
Angle PLC - Update on lab accreditation and ovarian study
10Jan22 07:00
ANGLE plc
-5.70%
Angle PLC - Insight into drug resistance in NSCLC
22Dec21 18:29
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
01Dec21 18:11
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
01Dec21 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix in RNA analysis of CTCs as tool in NSCLC
26Nov21 17:33
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
17Nov21 10:32
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
15Nov21 07:00
ANGLE plc
-5.70%
Angle PLC - Appointment of Chief Medical Officer
15Nov21 07:00
ANGLE plc
-5.70%
Angle PLC - Issue of LTIP Options and Share Options
12Nov21 17:51
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
12Nov21 07:00
ANGLE plc
-5.70%
Angle PLC - Participation at Jefferies healthcare conference
11Nov21 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix system showcased at NCRI Festival
10Nov21 17:40
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
02Nov21 07:00
ANGLE plc
-5.70%
Angle PLC - Change of Adviser
21Oct21 17:25
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
15Oct21 17:45
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep21 16:02
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Sep21 07:00
ANGLE plc
-5.70%
Angle PLC - Interim Results
27Sep21 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix demonstrates ability to isolate CTCs
22Sep21 07:00
ANGLE plc
-5.70%
Angle PLC - Study shows use of Parsortix to assess PD-L1
20Sep21 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix enables gene expression analysis in mPCa
07Sep21 07:00
ANGLE plc
-5.70%
Angle PLC - Notice of Interim Results and Webcast
24Aug21 07:00
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
09Aug21 07:00
ANGLE plc
-5.70%
Angle PLC - Study highlights superior performance of Parsortix
06Aug21 13:17
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
03Aug21 15:13
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
28Jul21 07:00
ANGLE plc
-5.70%
Angle PLC - Contract secured for bespoke assay development
09Jul21 07:00
ANGLE plc
-5.70%
Angle PLC - Harvesting CTCs from brain metastasis patients
07Jul21 18:34
ANGLE plc
-5.70%
Angle PLC - Director/PDMR Shareholding
02Jul21 10:45
ANGLE plc
-5.70%
Angle PLC - Issue of Equity
30Jun21 15:44
ANGLE plc
-5.70%
Angle PLC - Result of AGM
25Jun21 07:00
ANGLE plc
-5.70%
Angle PLC - Result of Accelerated Bookbuild
24Jun21 18:28
ANGLE plc
-5.70%
Angle PLC - Accelerated bookbuild to raise up to £20m
18Jun21 11:42
ANGLE plc
-5.70%
Angle PLC - Annual General Meeting update
18Jun21 07:00
ANGLE plc
-5.70%
Angle PLC - ctDNA and CTCs have differences in EGFR mutations
04Jun21 07:00
ANGLE plc
-5.70%
Angle PLC - Update on submission for FDA clearance
01Jun21 07:00
ANGLE plc
-5.70%
Angle PLC - Potential to prevent breast cancer relapse
20May21 07:00
ANGLE plc
-5.70%
Angle PLC - Parsortix demonstrates oesophageal cancer utility
19May21 16:37
ANGLE plc
-5.70%
Angle PLC - Exercise of options and total voting rights
11May21 07:00
ANGLE plc
-5.70%
Parsortix study uncovers targets in TNBC patients
30Apr21 11:22
ANGLE plc
-5.70%
Exercise of options and total voting rights
29Apr21 07:00
ANGLE plc
-5.70%
Preliminary Results
26Apr21 07:00
ANGLE plc
-5.70%
Ovarian cancer study patient enrolment completed
16Apr21 07:00
ANGLE plc
-5.70%
First large-scale pharma services contract secured
15Apr21 16:10
ANGLE plc
-5.70%
Notice of Preliminary Results and Webcast
12Apr21 07:00
ANGLE plc
-5.70%
ANGLE's Parsortix system showcased at AACR 2021
30Mar21 07:00
ANGLE plc
-5.70%
Global launch of clinical services laboratories
«
1
2
3
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Blogs
Academy
Insights
News
Research Tree
The Naked Fund Manager
Ideas & Picks
Ideas Hub
Stock Pick League
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
AIC Sectors
Asia Pacific
Asia Pacific Equity Income
Asia Pacific Smaller Companies
Biotechnology & Healthcare
China / Greater China
Commodities & Natural Resources
Country Specialist
Debt - Direct Lending
Debt - Loans & Bonds
Debt - Structured Finance
Environmental
Europe
European Smaller Companies
Farmland & Forestry
Financials
Flexible Investment
Global
Global Emerging Markets
Global Equity Income
Global Smaller Companies
Growth Capital
Hedge Funds
India
Infrastructure
Infrastructure Securities
Insurance & Reinsurance Strategies
Japan
Japanese Smaller Companies
Latin America
Leasing
Liquidity Funds
North America
North American Smaller Companies
Private Equity
Property - Debt
Property - Europe
Property - Rest of World
Property - UK Commercial
Property - UK Logistics
Property - UK Residential
Property Securities
Renewable Energy Infrastructure
Technology & Media
UK All Companies
UK Equity & Bond Income
UK Equity Income
UK Smaller Companies
VCT AIM Quoted
VCT Generalist
VCT Generalist Pre Qualifying
VCT Specialist: Environmental
VCT Specialist: Environmental Pre Qualifying
VCT Specialist: Healthcare & Biotechnology
Trust Managers
3i Group
3i Investments
Aberforth Partners
abrdn
AEW UK Investment Management
Albion Capital
Allianz Global Investors
Alpha Real Capital
Amati Global Investors
Amedeo Air Four Plus
Apax Guernsey Managers
Aquila Capital Investment
Artemis Investment Management
Asset Value Investors
Athelney Trust
Atrato Partners Limited
Augmentum Capital
Axiom Alternative Investments
Baillie Gifford
Baker Steel Capital
Beringea
BlackRock Investment Management (UK)
Boussard & Gavaudan Asset Management
Brevan Howard Capital Management
Chelverton Asset Management
Columbia Threadneedle
CVC Credit Partners
Doric Partners
Ecofin
Fidelity
Foresight Group
Frostrow Capital
Fundsmith
Gravis Capital Management
Greencoat Capital
Gresham House
Hansa Capital Partners
Harwood Capital
ICM
InfraRed Capital Partners
Invesco Asset Management
J.P. Morgan Asset Management
Janus Henderson Investors
Jupiter Unit Trust Managers
KKV Investment Management
Liontrust Asset Management
Markel CATCo Investment Management
Maven Capital Partners
MD Barnard and Co
Mercia Asset Management
Montanaro Investment Managers
Neuberger Berman Europe
New City Investment Managers
Octopus Investments
Pantheon Ventures
Phoenix Asset Management
Polar Capital Holdings
Premier Miton
Puma Investments
Quaero Capital
Rampart Capital
Ravenscroft
Riverstone International
Schroder Investment Management
Schroder Real Estate Management
Seneca Investment Managers
Triple Point Investment Management
Tritax Management
Troy Asset Management
TwentyFour Asset Management
White Oak Capital Partners
Willis Towers Watson
YFM Private Equity
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Align Research
BRR Media
Calvine Partners
Capital Access Group
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
goetzpartners securities Limited
Hardman & Co
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Radnor Capital Partners
Research Tree
SEAL Advisors Ltd
ShareSoc
The AIC
Trinity Delta
UK Investor Group
Vox Markets
Yellowstone Advisory
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cenkos Securities
Couloir Capital
Dowgate Capital
finnCap
First Berlin
First Sentinel
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Research
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
The Life Sciences Division
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Atrium Research
Auctus Advisors
Baptista Research
BNP Paribas Exane
BNP Paribas Exane - Sponsored Research
BRR Media
Bryan, Garnier & Co
Calderwood Capital
Calvine Partners
Canaccord Genuity
Capital Access Group
Cenkos Securities
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
finnCap
First Berlin
First Sentinel
Five Minute Pitch TV
goetzpartners securities Limited
Hannam & Partners
Hardman & Co
Hybridan
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Research
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Radnor Capital Partners
Research Tree
Resolve Research
SEAL Advisors Ltd
Shard Capital
ShareSoc
Shore Capital
SI Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Whitman Howard
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Video/Audio Interviews
BRR Media
Capital Access Group
Couloir Capital
Doceo
Edison
Equity Development
Five Minute Pitch TV
Mining Network
piworld.co.uk
Proactive
QuotedData
RaaS - Research as a Service
Research Tree
UK Investor Group
Vox Markets
Yellowstone Advisory
Event Providers
Capital Access Group
Cenkos Securities
Couloir Capital
Edison
Equity Development
Hardman & Co
InterAxS Global
Kepler | Trust Intelligence
London Stock Exchange
Mello Events
piworld.co.uk
Proactive
QuotedData
Research Tree
ShareSoc
The AIC
UK Investor Group
VSA Capital
Yellowstone Advisory
Contact
Sign Up
Sign In
Share: